Press release
Immunotherapy Drugs Market is Anticipated to Grow at CAGR of 10.1% During 2024-2031 | F. Hoffmann-La Roche AG, GlaxoSmithKline plc. AbbVie, Inc., Amgen, Inc., Merck & Co., Inc.
The Global Immunotherapy Drugs Market is estimated to reach at a CAGR of 10.1% during the forecast period (2024-2031).The Immunotherapy Drugs market report provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Leveraging a combination of qualitative and quantitative research methods, the company offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/immunotherapy-drugs-market?ophp
Medications that help boost or manipulate the body's immune system to fight diseases, particularly cancer. These can include monoclonal antibodies, checkpoint inhibitors, and cancer vaccines.
Forecast Growth Projected:
The Global Immunotherapy Drugs Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
List of the Key Players in the Immunotherapy Drugs Market:
F. Hoffmann-La Roche AG, GlaxoSmithKline plc. AbbVie, Inc., Amgen, Inc., Merck & Co., Inc., Alligator Bioscience, UbiVac, Bristol-Myers Squibb, Novartis International AG, and AstraZeneca plc, Daiichi Sankyo Company.
Industry Development:
➠ In February 2024, AbbVie acquired ImmunoGen, bolstering its oncology portfolio. ImmunoGen's flagship product, ELAHERE, is designed to target folate receptor-alpha-positive ovarian cancers. This strategic acquisition supports AbbVie's ongoing focus on strengthening its immunotherapy and oncology capabilities.
Research Methodology:
Our research methodology combines both qualitative and quantitative approaches to provide you with a thorough market analysis. We begin by gathering data from trusted industry reports and databases (secondary research), followed by primary research through surveys and interviews with key experts. We then apply advanced statistical tools to analyze the data, uncover trends, and assess market dynamics. Additionally, we use market segmentation and Porter's Five Forces analysis to evaluate competition. This approach ensures that the insights we provide are reliable, actionable, and tailored to support your decision-making process.
Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/immunotherapy-drugs-market?ophp
Market Dynamics:
Immunotherapy drugs are revolutionizing cancer treatment, and the market is growing rapidly due to advances in therapies like checkpoint inhibitors and CAR-T cell treatments. However, the high costs of these therapies and potential side effects are challenges. Opportunities lie in the development of combination therapies and treatments for other diseases.
Segment Covered in the Immunotherapy Drugs Market:
➠ By Drug Type (Monoclonal Antibodies, Vaccines, Interferons Alpha and Beta, Interleukins Checkpoint Inhibitors, Other)
➠ By Therapy Area (Cancer, Autoimmune and Inflammatory Diseases, Infectious Diseases, Others)
➠ By Distribution Channel (Hospitals, Clinics, Cancer Research Center, Other)
This Report Covers:
✔ Go-to-market Strategy.
✔ Neutral perspective on the market performance.
✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, Market Access, and other significant analysis, as well as development status.
✔Customized regional/country reports as per request and country level analysis.
✔ Potential & niche segments and regions exhibiting promising growth covered.
✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).
Regional Analysis for Immunotherapy Drugs Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Benefits of the Report:
➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Top-down and bottom-up approach for regional analysis
➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.
➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market
Speak to Our Senior Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/immunotherapy-drugs-market?ophp
Frequently asked questions:
➠ What is the global sales value, production value, consumption value, import and export of Immunotherapy Drugs market?
➠ Who are the global key manufacturers of the Immunotherapy Drugs Industry? How is their operating situation (capacity, production, sales, price, cost, gross, and revenue)?
➠ What are the Immunotherapy Drugs market opportunities and threats faced by the vendors in the global Immunotherapy Drugs Industry?
➠ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?
➠ What focused approach and constraints are holding the Immunotherapy Drugs market?
➠ What are the different sales, marketing, and distribution channels in the global industry?
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Immunotherapy Drugs Market is Anticipated to Grow at CAGR of 10.1% During 2024-2031 | F. Hoffmann-La Roche AG, GlaxoSmithKline plc. AbbVie, Inc., Amgen, Inc., Merck & Co., Inc. here
News-ID: 3842857 • Views: …
More Releases from DataM intelligence 4 Market Research LLP

United States Prime Editing and CRISPR Market 2025 | Growth Drivers, Key Players …
Market Size and Growth
Prime Editing and CRISPR Market is estimated to grow at a CAGR of 24.1% during the forecast period (2024-2031).
Key Development:
United States: Recent Industry Developments
✅ July 2025 - Prime Medicine announced an additional investment of up to $24 million from the Cystic Fibrosis Foundation to advance gene editing therapy targeting the G542X mutation, a prevalent cystic fibrosis-causing mutation with no current therapies.
✅ July 2025 - CRISPR…

United States Clinical Workflow Solutions Market 2025 | Growth Drivers, Market F …
Market Size and Growth
The Clinical Workflow Solutions Market size is growing at a high CAGR 12.3% during the forecast period (2023-2030).
Key Development:
United States: Recent Industry Developments
✅ In August 2025, Elation Health unveiled a significant AI expansion to its clinical-first platform, integrating native AI tools across all products at no additional cost. This enhancement aims to reduce administrative burdens and improve primary care workflows.
✅ In June 2025, Commure launched Commure Agents,…

United States Smart Robot Market 2025 | Growth Drivers, Market Forecast, Competi …
Market Size and Growth
The Global Smart Robot Market size is growing at a high CAGR during the forecast period (2024-2031).
Key Development:
United States: Recent Industry Developments
✅ In September 2025, ReWalk Robotics introduced an advanced lower-limb exoskeleton designed for stroke and spinal injury rehabilitation. This medical service robot aims to enhance mobility and independence for individuals with lower-limb disabilities, marking a significant advancement in healthcare robotics.
✅ In July 2025, Meta launched its…

United States Bio Active Protein Market 2025 | Growth Drivers, Market Forecast, …
Market Size and Growth
The Global "Bio Active Protein Market" is expected to grow at a CAGR during the forecast period 2024-2031
Key Development:
United States: Recent Industry Developments
✅ In September 2025, The Protein Brewery secured $35.6 million in Series B funding to scale its fungi-based bioactive protein production platform. The investment aims to accelerate the commercial launch of its sustainable protein ingredients in the U.S. and Singapore markets.
✅ In September 2025, Glanbia,…
More Releases for Immunotherapy
Immunotherapy Drugs Market
Immunotherapy Drugs Market Size reached US$ 288.02 Billion in 2024 and is expected to reach US$ 872.64 Billion by 2033, growing at a CAGR of 13.2% during the forecast period 2025-2033.
The Immunotherapy Drugs Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead…
Anti TIGIT Antibodies Revolutionizing Immunotherapy
Anti-TIGIT antibodies are at the forefront of a revolution in immunotherapy, representing a new class of immune checkpoint inhibitors that have the potential to transform the treatment landscape for cancer. Immunotherapy, which harnesses the body's immune system to fight cancer, has already made significant strides with the introduction of PD-1, PD-L1, and CTLA-4 inhibitors. However, the discovery and development of anti-TIGIT antibodies add a new dimension to this field, offering…
Allergy Immunotherapy Market Combating the Rising Tide: The Allergy Immunotherap …
Allergy Immunotherapy Market is to reach over USD 4.01 billion by the year 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Allergy Immunotherapy Market Size, Share & Trends Analysis Report By Treatment Type (SCIT, SLIT), By Allergy Type (Allergic Rhinitis, Asthma), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), Region, Market Outlook And Industry Analysis…
Allergy Immunotherapy Market - Empowering Resilience, Defying Allergies: Advanci …
Newark, New Castle, USA - new report, titled Allergy Immunotherapy Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Allergy Immunotherapy market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Allergy Immunotherapy market. The report offers an overview of the market, which…
Cancer Immunotherapy Market Cancer Immunotherapy Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Immunotherapy: Mending Cancer Regimens
1.1 Preface to Cancer Immunotherapy
1.2 Evolution of Cancer Immunotherapy
2. Categorization of Cancer Immunotherapy
2.1 Specific Cancer Immunotherapy
2.1.1 Cancer Vaccines
2.1.2 Monoclonal Antibodies
2.2 Non-Specific Cancer Immunotherapy
2.2.1 Adoptive Cell Transfer Immunotherapy
2.2.2 Immune Checkpoint Inhibitors
3. Fundamentals…
Global Cancer Immunotherapy Market & Cancer Immunotherapy Clinical Trials Outloo …
Pharmaceutical companies are actively engaged in research and development of cancer immunotherapies because of large unmet medical necessities. Investigators are trying to come forth with innovative cancer immunotherapeutic products having high safety and efficacy profiles which are not offered by conventional therapeutics.
Higher investments in research and development segment could significantly increase the drug discovery rates which will alleviate the medical condition of cancer patients. Simultaneously, technological advancements are being…